@Sage_Publishing @SageJournals | CVD research š«š„š| Open access | IF: 3.3 & 5-year IF: 3.0 | Indexed in: MEDLINE, PMC, WoS, Scopus | Social Media: Amy Goundry
London
Joined April 2022
- Tweets121
- Following542
- Followers207
- Likes246
Could emerging anti-inflammatory and immunomodulatory therapies transform cardiovascular care?
Our Special Collection on this topic is welcoming submissions until Dec 31, 2026.
@SageJournals #CardioImmunology #Cardiology #Inflammation
journals.sagepub.com/topic/cā¦
What role does inflammation play in atherosclerosis, heart failure and arrhythmias? Increasingly, the answer is: a central one.
Spotlight your research on targeting inflammation in CVD in our Special Collection led by Prof Arduino Mangoni. @SageJournals
journals.sagepub.com/topic/cā¦
This multicentre analysis from the European Registry of Type A Aortic Dissection (ERTAAD) compares outcomes after aortic root replacement versus supracoronary ascending aortic replacement.
Read the full findings:
journals.sagepub.com/doi/10.ā¦
Therapeutic Advances in Cardiovascular Disease retweeted
What does inclusive research look like?
Join our webinar on 14 Oct, 4 PM (London) to explore inclusive design, participation, trust & representation.
ow.ly/kfC550ZQaRs
ALT Free webinar on conducting inclusive research with practical choices for responsible methodology, scheduled for October 14, 2026, at 11am ET and 4pm BST.
Revisit this review on vasospastic angina (VSA), covering the mechanisms behind VSA, recommended diagnostic approaches, current management strategies, and important evidence gaps that still need to be addressed.
journals.sagepub.com/doi/10.ā¦
Revisit this review exploring current and emerging treatments for hereditary and wild-type transthyretin cardiac amyloidosis, alongside the limited benefits and practical challenges of diet and physical activity.
journals.sagepub.com/doi/10.ā¦
Therapeutic Advances in Cardiovascular Disease retweeted
š¢ Call for Papers | Explore immunity, inflammation, and cardiovascular disease links in this Special Collection from Therapeutic Advances in Cardiovascular Disease and Drug Safety.
Submit by 31 December 2026.
Learn more: ow.ly/8Cib50ZHEax @TACardio
How could 3D simulation support planning for complex abdominal aortic aneurysm repair?
This multicentre retrospective study compares 3D-assisted and conventional planning for fenestrated/branched EVAR.
journals.sagepub.com/doi/10.ā¦
#EVAR #VascularSurgery
How can cardiovascular treatment pathways be made safer and more patient-centred?
Our new Special Collection is now open for submissions:
journals.sagepub.com/topic/cā¦
The RESTORE-HF study evaluated the real-world effectiveness and safety of a torsemide-spironolactone fixed-dose combination in patients with heart failure with reduced ejection fraction.
Read the study: journals.sagepub.com/doi/10.ā¦
Drug-coated balloons offer a "leave-nothing-behind" approach to coronary intervention.
This real-world study reports 2-year outcomes following PCI with drug-coated balloons, including a comparison of sirolimus- and paclitaxel-coated devices.
journals.sagepub.com/doi/10.ā¦
Therapeutic Advances in Cardiovascular Disease retweeted
Join our webinar, "Publishing as a Clinician" to learn how to:
ā¢ Turn practice into research.
ā¢ Balance writing with patient care.
ā¢ Navigate journals open to practitioner perspectives.
Register: ow.ly/wQQm50ZeHB5
ALT Webinar
This review explores the growing role of coronary intravascular lithotripsy (IVL), from its mechanism of action and imaging guidance to evidence from the DISRUPT CAD trials and emerging applications in complex lesions.
journals.sagepub.com/doi/fulā¦
Therapeutic Advances in Cardiovascular Disease retweeted
Sageās How to Do Research and Get Published webinar series wins gold at 2026 EPIC Awards!
Find out more: ow.ly/HOHY50ZfZXA
Therapeutic Advances in Cardiovascular Disease
āNew impact factor of 3.3 (5āyear impact factor: 3.0)
A platform for clinical, decisionāfocused cardiovascular research, openly accessible to a global audience.
A huge thank you to our Editorial Board, authors, and reviewers!
Looking to share your research in a more accessible way? @TACardio welcomes PLSāPs, as well as video, podcast, & clinical image articles to help broaden reach and support engagement across wider audiences.
š©Considering these formats? Check requirements with the Managing Editor.
Writing up clinical research? Watch Sage's How to Do Research and Get Published webinar, "Mastering the Clinical Research Publication Journey: From Submitting to Publishing your Research", available on YouTube!
youtu.be/-N3zSHpIoDI?si=uspEā¦
Read this @TACardio review on sex-based differences across HF phenotypes and CV ageing mechanisms, summarising evidence on therapy response, and highlighting gaps due to under-representation in trials and under-treatment in practice.
journals.sagepub.com/doi/10.ā¦
š§ New podcast article (with transcript) in @TACardio!
journals.sagepub.com/doi/10.ā¦
